Congenital Toxoplasmosis Prevention SMFM's Podcast Series
-
- Education
Dr. Mandelbrodt discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii. The results were presented at the SMFM Annual Pregnancy Meeting in February 2018.
Dr. Mandelbrodt discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii. The results were presented at the SMFM Annual Pregnancy Meeting in February 2018.
5 min